Inventor · disambiguated record
Vahid Zia
Also filed as: ZIA VAHID
21 granted patents·12 pending applications·296 citations·filing 2004–2021
95Inventor score
Files withGILEAD PHARMASSET LLC16GILEAD SCIENCES INC8BONDY STEVEN S2DOWDY ERIC D2GILEAD SCIENCES LLC1
Top patents by PatentIndex Score
33 records- 0196US9682084B2Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2015·Granted Jun 20, 2017·21 cites·20 claims
- 0295US9708342B2Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olateGILEAD SCIENCES INC·Filed 2015·Granted Jul 18, 2017·20 cites·26 claims
- 0395US9549941B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2014·Granted Jan 24, 2017·39 cites·23 claims
- 0495US8889159B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2012·Granted Nov 18, 2014·114 cites·37 claims
- 0594US7754720B2Pyridazine compound and use thereofGILEAD SCIENCES INC·Filed 2007·Granted Jul 13, 2010·22 cites·16 claims
- 0692US10098886B2Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2017·Granted Oct 16, 2018·10 cites·19 claims
- 0791US10385067B2Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olateGILEAD SCIENCES INC·Filed 2017·Granted Aug 20, 2019·9 cites·19 claims
- 0891US10086011B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Granted Oct 2, 2018·8 cites·19 claims
- 0991US9757406B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Sep 12, 2017·9 cites·16 claims
- 1090US11707479B2Combination formulation of two antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Jul 25, 2023·1 cites·34 claims
- 1190US11116783B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2020·Granted Sep 14, 2021·2 cites·58 claims
- 1285US8329727B2Imidazo[4,5-c]pyridine compounds and methods of antiviral treatmentBONDY STEVEN S·Filed 2009·Granted Dec 11, 2012·9 cites·37 claims
- 1384US7648998B2Imidazo 4,5-c pyridine compounds and methods of antiviral treatmentLEUVEN K U RES & DEV·Filed 2004·Granted Jan 19, 2010·20 cites·33 claims
- 1482US8106054B2Crystalline pyridazine compoundDOWDY ERIC D·Filed 2008·Granted Jan 31, 2012·6 cites·17 claims
- 1575US10039779B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Aug 7, 2018·1 cites·16 claims
- 1674US9340568B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Granted May 17, 2016·4 cites·10 claims
- 1774US2020188419A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Application pending·0 cites
- 1870US11202780B2Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2020·Granted Dec 21, 2021·0 cites·21 claims
- 1969US7767850B2S-[2-[(1-iminoethy)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline saltPFIZER·Filed 2008·Granted Aug 3, 2010·1 cites·10 claims
- 2064US2019240246A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Application pending·0 cites
- 2162US8569487B2Pyridazine compound and use thereofBONDY STEVEN S·Filed 2007·Granted Oct 29, 2013·0 cites·1 claims
- 2262US2015064253A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 2361US2019111068A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Application pending·0 cites
- 2460US2014212491A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 2560US2019015420A1Crystalline forms of (2r,5s,13ar)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2658US2017348342A1Compositions and methods for treating hepatitis c virusGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 2753US2014212487A1Solid dispersion formulation of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 2853US2016120892A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Application pending·0 cites
- 2952US8569488B2Crystalline pyridazine compoundDOWDY ERIC D·Filed 2011·Granted Oct 29, 2013·0 cites·19 claims
- 3052US2015064252A1Solid dispersion formulation of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 3146US2008039487A1Processes and intermediates useful for preparing integrase inhibitor compoundsGILEAD SCIENCES LLC·Filed 2006·Application pending·0 cites
- 3246US2005038120A1S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline saltFiled 2004·Application pending·0 cites
- 3337US10786518B2Compositions and methods of treating HIVJANSSEN SCIENCES IRELAND UC·Filed 2018·Granted Sep 29, 2020·0 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →